Asahi Kasei Pursues M&A to Grow Pharmaceuticals Business in Europe Nov. 17, 2021 Filed Under: Pharma Tagged With: asahi kasei, business strategy, M&A, pharmaceuticalAsahi Kasei Corp. (TYO:3407) is looking to expand its overseas operations in the pharmaceuticals business. Having already bolstered its business…... Please subscribe to read the full story. Subscribe Free Trial Related Articles:Asahi Kasei Targets US Market in Bid to Become Global Health…Asahi Kasei Leans on Zoll Acquisition to Accelerate Growth…Asahi Kasei Targets Sales of 1 Trillion Yen in Health Care…Asahi Kasei Medical to Enter Pharmaceutical CDMO BusinessMitsui Chemicals to Acquire Asahi Kasei's Pellicle Business…Asahi Kasei Gets CVC Operations Under Way in China